» Articles » PMID: 9533450

Activation of the Extracellular Signal-regulated Kinase Pathway is Differentially Required for TCR-stimulated Production of Six Cytokines in Primary T Lymphocytes

Overview
Journal Int Immunol
Date 1998 Apr 9
PMID 9533450
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The extracellular signal-regulated kinase (ERK) signaling pathway is strongly activated in response to TCR stimulation in normal T cells. However, the extent to which activation of the ERK pathway is necessary for TCR-stimulated cytokine production is not clear. We have addressed this question by use of two separate methods to interfere with TCR activation of the ERK cascade. The first approach utilized transient expression of a catalytically inactive form of mitogen-activated/ERK 1 (CI-MEK1), while the second involved using the MEK1- and MEK2-specific inhibitor PD98059 to block ERK activation by the TCR. In order to assess the requirement for ERK activation in T cell cytokine production, we have measured the effect of ERK inhibition upon the production of six cytokines, IL-3, IL-4, IL-5, IL-10, granulocyte macrophage colony stimulating factor (GM-CSF) and IFN-gamma, by newly activated normal mouse T cells in response to TCR stimulation. The results of experiments using both methods to block ERK activation have revealed a requirement for intact ERK signaling for the full elicitation of TCR-stimulated cytokine production. Dose-response analyses using the MEK inhibitor PD98059 showed that the TCR-stimulated production of all cytokines measured was affected by this treatment. However, the production of IL-3 and IL-4 was only partially dependent upon ERK activation, whereas IL-5, IL-10, IFN-gamma and GM-CSF production was severely affected by diminished ERK activation. We conclude that the ERK pathway is differentially involved in the activation of different cytokine genes in normal T cells.

Citing Articles

Regulation of CD8 T-cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid.

Torres R, Turner J, DAntonio M, Pelanda R, Kremer K Immunol Rev. 2023; 317(1):203-222.

PMID: 37096808 PMC: 10523933. DOI: 10.1111/imr.13208.


Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial Cells.

Osanyinlusi S, Zischke J, Jacobs R, Weissinger E, Schulz T, Kay-Fedorov P mBio. 2022; 13(6):e0294622.

PMID: 36445084 PMC: 9765415. DOI: 10.1128/mbio.02946-22.


Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8 T Cell Receptor Signaling.

Gonzalez-Perez G, Lamouse-Smith E Front Immunol. 2017; 8:265.

PMID: 28337207 PMC: 5340779. DOI: 10.3389/fimmu.2017.00265.


Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.

Bunse C, Tischer S, Lahrberg J, Oelke M, Figueiredo C, Blasczyk R Clin Exp Immunol. 2016; 185(1):107-18.

PMID: 26990855 PMC: 4908295. DOI: 10.1111/cei.12794.


Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.

Crawford T, Hecht F, Pilcher C, Ndhlovu L, Barbour J PLoS One. 2013; 8(10):e77412.

PMID: 24143233 PMC: 3797111. DOI: 10.1371/journal.pone.0077412.